XBI
State Street SPDR S&P Biotech ETF
$145.04−0.24 (−0.17%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Feb 6, 2006 – Nov 18, 2026, Dividends reinvested
- Final balance
- $93,439
- CAGR
- +11.35%
- Max drawdown
- −63.89%
Trailing returns (%)
XBI's average annual return was 8.35% over the last 10 years and 11.50% over the last 20 years, through Nov 18, 2026. $10,000 in XBI on Nov 18, 2016 grew to $22,290 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +0.50%
- 3M
- −9.41%
- 6M
- +13.72%
- YTD
- +19.07%
- 1Y
- +26.47%
Per year
- 3Y
- +26.18%
- 5Y
- +3.61%
- 10Y
- +8.35%
- 15Y
- +14.46%
- 20Y
- +11.50%
- Since 2006
- +11.35%
Annual returns
2006 from Feb 6 · 2026 through Nov 18
XBI returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +19.07% |
| 2025 | +35.89% |
| 2024 | +1.01% |
| 2023 | +7.60% |
| 2022 | −25.87% |
| 2021 | −20.45% |
| 2020 | +48.33% |
| 2019 | +32.56% |
| 2018 | −15.28% |
| 2017 | +43.77% |
| 2016 | −15.45% |
| 2015 | +13.58% |
Metrics
Since 2006| Volatility | 30.60% |
|---|---|
| Sharpe ratio | 0.51 |
| Sortino ratio | 0.73 |
| Calmar ratio | 0.18 |
| Longest drawdown | 5.8 years |
Worst drawdowns
Since 2006| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −63.9% | Feb 2021 | May 2022 | Not yet | 5.8 years so far |
| −49.2% | Jul 2015 | Feb 2016 | Jan 2018 | 2.5 years |
| −37.6% | Aug 2008 | Mar 2009 | Apr 2011 | 2.7 years |
| −35.3% | Jun 2018 | Dec 2018 | May 2020 | 1.9 years |
| −29.1% | Feb 2014 | May 2014 | Oct 2014 | 8 months |